Medigene AG Statistics

Total Valuation

Medigene AG has a market cap or net worth of GBP 1.67 million. The enterprise value is -8.09 million.

Market Cap	1.67M
Enterprise Value	-8.09M

Important Dates

The next estimated earnings date is Friday, August 15, 2025.

Earnings Date	Aug 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.65%
Shares Change (QoQ)	+5.09%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	14.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.27
PB Ratio	0.10
P/TBV Ratio	0.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.60
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.64

Financial Position

The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.13.

Current Ratio	2.39
Quick Ratio	2.22
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	-0.17
Interest Coverage	-28.34

Financial Efficiency

Return on equity (ROE) is -63.93% and return on invested capital (ROIC) is -34.49%.

Return on Equity (ROE)	-63.93%
Return on Assets (ROA)	-27.15%
Return on Invested Capital (ROIC)	-34.49%
Return on Capital Employed (ROCE)	-69.20%
Revenue Per Employee	72,562
Profits Per Employee	-155,268
Employee Count	76
Asset Turnover	0.21
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.00% in the last 52 weeks. The beta is 0.92, so Medigene AG's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	-95.00%
50-Day Moving Average	1.09
200-Day Moving Average	2.30
Relative Strength Index (RSI)	23.55
Average Volume (20 Days)	19,480

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medigene AG had revenue of GBP 6.31 million and -13.51 million in losses. Loss per share was -1.07.

Revenue	6.31M
Gross Profit	5.05M
Operating Income	-13.07M
Pretax Income	-13.24M
Net Income	-13.51M
EBITDA	-12.53M
EBIT	-13.07M
Loss Per Share	-1.07

Full Income Statement

Balance Sheet

The company has 11.89 million in cash and 2.16 million in debt, giving a net cash position of 9.73 million.

Cash & Cash Equivalents	11.89M
Total Debt	2.16M
Net Cash	9.73M
Net Cash Per Share	n/a
Equity (Book Value)	16.67M
Book Value Per Share	1.13
Working Capital	7.71M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.02 million and capital expenditures -526,496, giving a free cash flow of -12.54 million.

Operating Cash Flow	-12.02M
Capital Expenditures	-526,496
Free Cash Flow	-12.54M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 79.94%, with operating and profit margins of -207.04% and -213.98%.

Gross Margin	79.94%
Operating Margin	-207.04%
Pretax Margin	-209.76%
Profit Margin	-213.98%
EBITDA Margin	-198.51%
EBIT Margin	-207.04%
FCF Margin	n/a

Dividends & Yields

Medigene AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.65%
Shareholder Yield	-2.65%
Earnings Yield	-807.25%
FCF Yield	-749.54%

Stock Splits

The last stock split was on August 29, 2024. It was a reverse split with a ratio of 0.5.

Last Split Date	Aug 29, 2024
Split Type	Reverse
Split Ratio	0.5

Scores

Medigene AG has an Altman Z-Score of -22.4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-22.4
Piotroski F-Score	n/a